Humacyte Inc (HUMA)
4.09
+0.10
(+2.51%)
USD |
NASDAQ |
Apr 29, 16:00
4.09
0.00 (0.00%)
Pre-Market: 20:00
Humacyte Shareholders Equity (Quarterly): 13.55M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.55M |
| September 30, 2023 | 36.99M |
| June 30, 2023 | 61.12M |
| March 31, 2023 | 81.89M |
| December 31, 2022 | 116.93M |
| September 30, 2022 | 118.67M |
| Date | Value |
|---|---|
| June 30, 2022 | 142.26M |
| March 31, 2022 | 103.89M |
| December 31, 2021 | 122.17M |
| September 30, 2021 | 75.86M |
| December 31, 2020 | -350.32M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-350.32M
Minimum
Dec 2020
142.26M
Maximum
Jun 2022
47.55M
Average
81.89M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Adial Pharmaceuticals Inc | 4.084M |
| Gritstone Bio Inc | 51.85M |
| Precision BioSciences Inc | 18.86M |
| Puma Biotechnology Inc | 53.44M |
| Revance Therapeutics Inc | -151.60M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 128.22M |
| Total Liabilities (Quarterly) | 114.68M |